Comparison between Hyper-CVAD and PETHEMA ALL-93 in Adult Acute Lymphoblastic Leukemia: A Single-Center Study
Conclusions: Although Hyper-CVAD and PE THEMA ALL-93 showed similar effects, Hyper-CVAD was tolerated better. Age and comorbidities should be taken into account before a chemotherapy regimen is determined for patients with ALL.Chemotherapy 2018;63:207 –213
Source: Chemotherapy - Category: Cancer & Oncology Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Aspergillosis | Aspergillus | Cancer & Oncology | Chemotherapy | Hematology | Hypofibrinogenemia | Leukemia | Pediatrics | Skin | Study